Psilocybin, Brain Health and Longevity

In the second wave of psychedelic research, there are multiple trials taking place across the world.

This includes looking into their potential use to treat end-of-life anxiety and depression in the terminally ill (at the US’s John Hopkins University and NYU), for smoking cessation, alcoholism, anorexia, OCD, asthma, longevity and pain syndromes, as well as seven separate trials worldwide into the use of psilocybin to treat depression.

Read more

Evolution of Psychedelics

Because psychedelics can have profoundly positive effects on people, this has led to the narrative that they exist for our consumption.

Why else would certain plants and mushrooms have evolved compounds that foster better mental health, induce spiritual and transformative experiences, and lead to enhanced connection to others and nature?

However, there is evidence that suggests the opposite (more banal) reality: these compounds have functions that have nothing to do with us.

Read more